Novocure
Baruch Narotzki PhD has extensive experience in clinical development and data management, currently serving as Senior Manager and New Indications Lead at Novocure since February 2020. Prior to this role, Baruch worked at UroGen Pharma from January 2015 to February 2020, handling responsibilities as CRA, Data Manager, and Clinical Project Manager, including database management and statistical analysis. Educationally, Baruch obtained a Ph.D. in Medical Sciences from Technion - Israel Institute of Technology, where also served as a teaching assistant in various courses. Additionally, Baruch has worked as a dietitian and personal trainer, providing nutritional counseling and exercise tutoring.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.